思康睿奇(上海)药业有限公司 Mediaroom - PR Newswire APAC

Search

思康睿奇(上海)药业有限公司

Latest News

Early Data Show Highly Selective FGFR2 Inhibitor 3HP-2827 Active in Advanced CCA; Chinese Academy of Sciences' Zhou Jian Comments on Potential for Patients With FGFR2 Alterations

CHICAGO, June 2, 2026 /PRNewswire/ -- At the 2026 American Society of Clinical Oncology (ASCO) Annu...

2026-06-02 21:30 5860